UTime Initiates Financial and Legal Due Diligence on Bowen Therapeutics, Business News

SHENZHEN, China, Aug. 29, 2024 /PRNewswire/ — UTime Limited (NASDAQ: WTO) (“UTime” or the “Company”), which continues to build on its strengths in the global healthcare sector, has announced that it has commenced a comprehensive financial and legal due diligence on Bowen Therapeutics Inc (“Bowen Therapeutics”), which it intends to acquire. The move marks an…